Literature DB >> 3984160

Erythrocyte membrane alterations associated with the attachment and replication of Eperythrozoon suis: a light and electron microscopic study.

J F Zachary, E J Basgall.   

Abstract

Erythrocytes from pigs with experimental porcine eperythrozoonosis were examined using light microscopy and scanning and transmission electron microscopy. Three distinct forms of Eperythrozoon suis were attached to the plasma surface of erythrocyte membrane. Erythrocytes were initially parasitized by one or several immature forms. Immature forms enlarged and developed into juvenile and mature forms. The parasite replicated by budding of small immature forms from larger immature forms, juvenile forms, and mature forms. Small immature forms attached to adjacent membrane of the same erythrocyte or a nonparasitized erythrocyte. E. suis organisms were intimately associated with, but distinctly separated from erythrocyte membrane by a 30-nm electron lucent zone. Cell membrane in this area was denser than adjacent nonparasitized membrane. Early interaction between erythrocyte membrane and small immature forms resulted in no membrane deformation, but as this form enlarged, it later became embedded in a deep cup-like membrane invagination. As the immature form developed into the juvenile form a shallow, broad-based depression was observed in the membrane. A similar depression that covered a greater surface area was observed in the membrane parasitized by the mature form. The interaction between the parasitic forms and erythrocyte membrane resulted ultimately in severe membrane deformation. Parasite-membrane interactions may play an important role in the development of misdirected immune responses in experimental porcine eperythrozoonosis.

Entities:  

Mesh:

Year:  1985        PMID: 3984160     DOI: 10.1177/030098588502200211

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  7 in total

1.  Alteration of integrin-associated protein (CD47) on experimental porcine eperythrozoonosis.

Authors:  Wei Li; Ning Du; Binrui Xu; Weixing Dong; Zhe Qu; Yong Wang; Yanping Sui
Journal:  Vet Res Commun       Date:  2008-02-23       Impact factor: 2.459

2.  Insights into the gene expression profile of uncultivable hemotrophic Mycoplasma suis during acute infection, obtained using proteome analysis.

Authors:  Kathrin M Felder; Paula M Carranza; Peter M Gehrig; Bernd Roschitzki; Simon Barkow-Oesterreicher; Katharina Hoelzle; Katharina Riedel; Michael Kube; Ludwig E Hoelzle
Journal:  J Bacteriol       Date:  2012-01-20       Impact factor: 3.490

3.  Mycoplasma suis antigens recognized during humoral immune response in experimentally infected pigs.

Authors:  L E Hoelzle; K Hoelzle; M Ritzmann; K Heinritzi; M M Wittenbrink
Journal:  Clin Vaccine Immunol       Date:  2006-01

4.  Inorganic pyrophosphatase in uncultivable hemotrophic mycoplasmas: identification and properties of the enzyme from Mycoplasma suis.

Authors:  Katharina Hoelzle; Simone Peter; Michele Sidler; Manuela M Kramer; Max M Wittenbrink; Kathrin M Felder; Ludwig E Hoelzle
Journal:  BMC Microbiol       Date:  2010-07-20       Impact factor: 3.605

5.  Antibodies to actin in autoimmune haemolytic anaemia.

Authors:  Kathrin M Felder; Katharina Hoelzle; Karl Heinritzi; Mathias Ritzmann; Ludwig E Hoelzle
Journal:  BMC Vet Res       Date:  2010-03-30       Impact factor: 2.741

6.  Complete genome sequence of Mycoplasma suis and insights into its biology and adaption to an erythrocyte niche.

Authors:  Ana M S Guimaraes; Andrea P Santos; Phillip SanMiguel; Thomas Walter; Jorge Timenetsky; Joanne B Messick
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

7.  Mycoplasma suis infection results endothelial cell damage and activation: new insight into the cell tropism and pathogenicity of hemotrophic mycoplasma.

Authors:  Albina Sokoli; Katrin Groebel; Katharina Hoelzle; Werner M Amselgruber; José M Mateos; Mårten K J Schneider; Urs Ziegler; Kathrin M Felder; Ludwig E Hoelzle
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.